What Is the First-Line Treatment of Unspecified Respiratory Failure?
Unspecified acute respiratory failure (ARF) demands prompt, structured management centred on restoring safe oxygenation while addressing the cause of hypoxemia. The evidence-based protocol covers the preferred oxygenation strategy, the recommended oxygen delivery approach, and the pharmacotherapeutic framework.
Clinical Target
The primary goal is maintaining PaO2 between 70 and 110 mmHg. Network meta-analysis data support this window: survival disadvantage has been demonstrated at PaO2 targets below 75 mmHg and at values of 150 mmHg or above. The strategy explicitly avoids both excess hypoxemia and hyperoxemia.
Treatment Approach
The protocol follows a traditional oxygenation strategy and specifies a preferred non-invasive oxygen delivery modality supported by evidence of lower mortality and reduced intubation risk. Pharmacotherapy is directed at the underlying disease causing hypoxemia. When a respiratory infection cannot be excluded, a defined class of broad-spectrum antibiotic coverage is incorporated.
The complete regimen — delivery modality, its evidence basis, and the full antibiotic framework — is contained in the structured protocol.
References
DOI: 10.1186/s40560-023-00658-3
- As a recent network meta-analysis demonstrated decreased survival in patients with a PaO2 target of 55–75 mmHg and patients with a PaO2 ≥ 150 mmHg, it seems appropriate to follow the traditional oxygenation strategy that avoids excess hypoxemia and hyperoxemia.
- In these studies, the actual difference between study groups was 15–28 mmHg in PaO2 or 1–4% in SaO2, and PaO2 was maintained between 70 and 110 mmHg in both groups in all studies.
- In the HFNC guidelines by the American College of Physicians, HFNC was weakly recommended for ARF over NPPV due to a systematic review reporting that HFNC for ARF is associated with lower mortality and a lower intubation rate compared to NPPV.
- In ARF, pharmacotherapy should be focused on the underlying disease or diseases that are causing hypoxemia.
- In situations where respiratory infections cannot be ruled out, the use of broad-spectrum antibiotic regimens including a macrolide or new quinolone is often considered.
View source ↗